Loozy Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10
Best for: people who want semaglutide or tirzepatide on a 3-month plan from a brand that names its doctors and pharmacy
Price is where Loozy scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Billed separately
No insurance needed · Vetted by our editors
Loozy is a casual-toned telehealth brand selling compounded semaglutide and tirzepatide as a 3-month membership paid upfront, with prescribing by Elite Care Health and fulfillment by Rx Ave Health. Semaglutide starts at $199/mo ($597 per 3 months) and tirzepatide at $249/mo ($747); lower-cost microdosing plans exist, and the price rises when you move to higher doses.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Loozy
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Brightmeds
Best for: compounded or brand GLP-1 bundled with TRT and peptides for men
Editorial score · methodology
Direct Meds
Best for: listed for disclosure only — see its FDA warning and BBB complaints first
Editorial score · methodology
Loozy at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $149/mo (Listed in the intake plan menu as "$447 for 3 months." Fixed low dose.)
- Pricing model
- Scales with dose — higher doses cost more
- What's included
- Medication · Consult
- FDA status
- No FDA warning letter on record
How we scored Loozy
Each dimension is scored algorithmically from Loozy’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.1/10At $149/mo, Loozy runs about 12% below the $169 median for GLP-1 providers. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
7.1/10Loozy offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.8/10Online intake and platform experience — ongoing clinician messaging, consult included in the price; 7 platform features disclosed.
Trust & Safety15%
6.3/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.5/10Loozy's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
5.0/10Coaching not included in the base price, clinician messaging between visits.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Loozy review
Last checked September 2026- Confirmed current pricing across 7 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $149–$370/mo across 7 dose/plan tiers — checked September 2026
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Loozy
We walked Loozy’s public signup flow in September 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Tap "get started" on the homepage, which opens the intake on a separate start page
- 2Pick your health goals, sex at birth, date of birth, height, current weight and goal weight
- 3Choose your state
- 4A "Before we continue" pop-up asks for first and last name, email, phone and SMS consent (walk stopped here)
- 5Per the intake's own page list, next come pregnancy, conditions, medications, allergies, alcohol and GLP-1 history questions, then consent, plan choice, shipping, checkout and a government ID upload
- The homepage shows only the semaglutide starting price ($199/mo billed as a 3-month plan); tirzepatide and microdosing prices sit inside the intake
- The contact pop-up checks that your email can receive mail and rejected both a placeholder address and a disposable inbox
- Every plan is billed as a 3-month block, and the plan for your next block costs more once you move past the starter doses
- Patients in Arkansas, DC, Kansas, Mississippi, New Jersey, New Mexico, Rhode Island, Virginia and West Virginia are routed to a scheduled video call before a prescription
- A government ID upload is required after checkout
- Homepage testimonials are labeled "illustrative composites, not verified outcomes"
- We did not take the medication, and nothing here describes a patient outcome
Loozy customer support
- support@loozy.care
GLP-1 medications Loozy offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Homepage: "$199/mo, billed as a 3-month plan." Membership includes the consult.
The next 3-month block after Starter costs $657.
Listed in the intake plan menu as "$447 for 3 months." Fixed low dose.
Tirzepatide pricing appears only inside the intake, not on the homepage.
$998 per 3 months, about $332.67/mo.
$1,110 per 3 months.
Listed in the intake plan menu as "$647 for 3 months," about $215.67/mo.
Ready to get started?
Plans and promotions change often — check Loozy's current pricing and active discounts before you decide.
What we like
- Names its medical group (Elite Care Health) and its pharmacy (Rx Ave Health), which many brands never disclose
- Semaglutide starts at $199/mo on a 3-month plan, with a $149/mo microdosing option
- Membership covers the provider review, dose titration, medication and unlimited async messaging
- Full refund if you cancel before a provider reviews your intake; $59 kept if you are not approved
- Cash-pay with HSA/FSA use suggested, so no insurance paperwork
- Offers both compounded semaglutide and tirzepatide, plus low-dose microdosing plans
Watch-outs
- No month-to-month option: every plan is a 3-month membership charged in full upfront
- Price rises as you move up in dose: semaglutide goes from $597 to $657 per 3 months, tirzepatide from $747 to $1,110
- Tirzepatide prices are not on the homepage; you only see them inside the intake
- You must give your name, email and phone before seeing plans, and throwaway emails are rejected
- Membership fees are non-refundable once a provider has reviewed your intake, apart from the partial refunds in the policy
- Homepage testimonials are labeled "illustrative composites," not real patient reviews
- State coverage is described three different ways and no state list is published
- Support is email-only; no phone number is published
Is Loozy worth it?
Loozy built its program around one core idea: people who want semaglutide or tirzepatide on a 3-month plan from a brand that names its doctors and pharmacy. It runs $149/month — toward the affordable end of the category, so cost isn't the reason to look elsewhere. It's a fairly plain, no-frills entry in the glp-1 providers category, without a lot of extra add-ons layered on top of the medication itself.
On top of the core program, it offers a microdosing option and takes HSA/FSA payment.
How much Loozy actually costs
Compounded semaglutide runs $199/month, compounded semaglutide runs $219/month, compounded semaglutide runs $149/month, compounded tirzepatide runs $249/month, compounded tirzepatide runs $333/month, compounded tirzepatide runs $370/month, and compounded tirzepatide runs $216/month.
That puts Loozy below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
altRX (about $149/month) is one of the closest alternatives to weigh Loozy against.
Medications: what Loozy prescribes
Loozy prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who Loozy is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost — $149/month is below the roughly $169 median we track across the category.
- value being able to message a clinician between visits instead of waiting on the next scheduled one.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Loozy offers clinician messaging between visits, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Loozy earns its place on the shortlist mainly on price: at $149/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where Loozy scores best in our breakdown.
Ready to start with Loozy?
Starting at $149/month. See current pricing and start your free consultation.
Loozy might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Loozy review:
Sources & methodology — as of September 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Loozy's current pricing
Plans start at $149/month. Start your free consultation to check eligibility and today's price.